DRKS00018102尚未招募不适用
Molecular diagnostics of brain tumors using third-generation sequencing - nanoDx
Charité Campus Charité Mitte0 个研究点目标入组 211 人开始时间: 2021年5月21日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 211
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- one 至 one（—）
- 性别
- All
入选标准
- •Female or male individuals with planned biopsy or resection of a suspected brain tumor as part of routine clinical procedures, who have given written informed consent.
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
iquid biopsy of brain tumors using cerebrospinal fluid analysisCTRI/2022/06/042986Strand Life Sciences Pvt Ltd
尚未招募
不适用
*Non-invasive phenotyping of molecular brain tumour profiles using novel advanced MR imaging and analysis'GliomaNL-OMON47240Erasmus MC, Universitair Medisch Centrum Rotterdam300
进行中（未招募）
1 期
Tumor profilingPatients with locally advanced and/ or metastasized carcinoma for whom no further evidence-based drug treatment is established.A progression of the tumor is confirmed due to the last evidence-based drug therapy. Due to circulating tumor-DNA (ctDNA) in a blood sample and/or tissue sample of metastasis, a molecular-biologic tumor profiling is performed and an adapted tumor-specific drug therapy is selected.EUCTR2014-005341-44-ATMedical University of Graz64
进行中（未招募）
4 期
Are RNA signatures (biomarkers) in the tissue which surrounds the joints (synovial tissue) from patients with rheumatoid arthritis predictive of response to drug treatments?Musculoskeletal DiseasesRheumatoid arthritisISRCTN44988547Queen Mary University of London240
招募中
1 期
The 3TR Molecular Pathobiology-Driven Precision Therapy in RA (3TR Precis-The-RA) studyMedDRA version: 21.0Level: PTClassification code: 10039073Term: Rheumatoid arthritis Class: 100000004859Rheumatoid ArthritisCTIS2022-502021-18-00Queen Mary University Of London240